StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pre-Open Stock Movers 08/18: (OMER) (ESPR) (SUNE) (DKS) (HD) Higher; (APP) (SNDK) (WMT) Lower (more...)
August 18, 2015 9:30 AM
Omeros (NASDAQ: OMER) 64.4% HIGHER; announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Special Reports
Next Articles
UBS Cuts Price Target on Wal-mart (WMT) to $75 Following 2Q16
August 19, 2015 10:07 AM
Baird Cuts Price Target on TerraForm Power (TERP) to $32 on Long-Term Growth Concerns
August 19, 2015 7:46 AM
Needham & Company Raises Price Target on SunEdison (SUNE) Following Recent Financing
August 19, 2015 6:43 AM
Summit Research Reiterates Buy on Cheetah Mobile (CMCM) Following 2Q15
August 18, 2015 2:13 PM
Needham & Company Reiterate Buy on Seattle Genetics (SGEN) Following Adcetris Approval
August 18, 2015 11:12 AM
Leerink Partners Remain Bullish on Seattle Genetics (SGEN) Following FDA's Approval of Adcetris
August 18, 2015 10:13 AM
